Related Experiment Videos

[Cefoperazone, cefsulodin and ceftazidime--3 cephalosporins active against Pseudomonas in comparison with their

Zentralblatt Fur Bakteriologie, Mikrobiologie Und Hygiene. 1. Abt. Originale A, Medizinische Mikrobiologie, Infektionskrankheiten Und Parasitologie = International Journal of Microbiology and Hygiene. A, Medical Microbiology, Infectious
|April 1, 1983
PubMed

Insights

Ceftazidime demonstrates superior in vitro activity against Pseudomonas aeruginosa compared to other cephalosporins and their monobactam analogues. This study highlights ceftazidime

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Pseudomonas aeruginosa is an opportunistic pathogen known for its resistance to antibiotics.
  • Beta-lactam antibiotics, including cephalosporins and monobactams, are crucial for treating P. aeruginosa infections.
  • Understanding the in vitro activity of these agents is essential for guiding clinical treatment.

Purpose of the Study:

  • To compare the in vitro activity of ceftazidime, cefoperazone, cefsulodin, and their monobactam analogues against Pseudomonas aeruginosa.
  • To investigate the impact of media composition, human serum, and anaerobic conditions on antibiotic efficacy.
  • To assess the inoculum effect as an indicator of beta-lactamase instability.

Main Methods:

  • In vitro susceptibility testing of 144 P. aeruginosa strains.
  • Determination of Minimum Inhibitory Concentrations (MICs) for tested antibiotics.
  • Evaluation of media variation, human serum presence, and anaerobic conditions on MIC values.
  • Assessment of inoculum effect to identify beta-lactamase instability.

Main Results:

  • Ceftazidime exhibited the highest in vitro activity, inhibiting most P. aeruginosa strains at concentrations of 2-4 µg/ml.
  • All tested monobactam analogues showed lower activity than their corresponding cephalosporins.
  • The monobactam analogue of ceftazidime was the most effective among the monobactams, while the cefsulodin analogue was inactive against P. aeruginosa.

Conclusions:

  • Ceftazidime is a highly effective cephalosporin against Pseudomonas aeruginosa in vitro.
  • Monobactam analogues generally display reduced activity compared to parent cephalosporins.
  • The study underscores the importance of ceftazidime in treating P. aeruginosa infections, with specific monobactams showing limited utility.

Related Concept Videos